D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth

@inproceedings{Ma2015D2hydroxyglutarateIE,
  title={D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth},
  author={Shenghong Ma and Bowen Jiang and Wanglong Deng and Zhong-Kai Gu and Fei-Zhen Wu and Tingting Li and Yukun Xia and Hui Yang and Dan Ye and Yue Xiong and Kun Liang Guan},
  booktitle={Oncotarget},
  year={2015}
}
Cancer-associated isocitrate dehydrogenase (IDH) 1 and 2 mutations gain a new activity of reducing α-KG to produce D-2-hydroxyglutarate (D-2-HG), which is proposed to function as an oncometabolite by inhibiting α-KG dependent dioxygenases. We investigated the function of D-2-HG in tumorigenesis using IDH1 and IDH2 mutant cancer cell lines. Inhibition of D-2-HG production either by specific deletion of the mutant IDH1-R132C allele or overexpression of D-2-hydroxyglutarate dehydrogenase (D2HGDH… CONTINUE READING
14 Citations
36 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Characterization of the human prolyl 4-hydroxylases that modify the

  • M Hirsila, V Koivunen P Fau - Gunzler, KI Gunzler V Fau - Kivirikko, J Kivirikko Ki Fau - Myllyharju, J. Myllyharju
  • The Journal of biological chemistry
  • 2003
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…